Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history

Ratios

vs
industry
vs
history
P/E(ttm) 18.98
FBT's P/E(ttm) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. FBT: 18.98 )
Ranked among companies with meaningful P/E(ttm) only.
FBT' s P/E(ttm) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 23.26
Current: 18.98
0
23.26
PE(NRI) 18.98
FBT's PE(NRI) is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. FBT: 18.98 )
Ranked among companies with meaningful PE(NRI) only.
FBT' s PE(NRI) Range Over the Past 10 Years
Min: 0  Med: 0 Max: 23.26
Current: 18.98
0
23.26
P/B 4.85
FBT's P/B is ranked lower than
100% of the Companies
in the Global industry.

( Industry Median: vs. FBT: 4.85 )
Ranked among companies with meaningful P/B only.
FBT' s P/B Range Over the Past 10 Years
Min: 0  Med: 0 Max: 6.17
Current: 4.85
0
6.17

Buy Back

vs
industry
vs
history

More Statistics

Short Percentage of Float0.00%
52-Week Range $78.18 - 114.62
Shares Outstanding (Mil)8,800,002.00
» More Articles for FBT

Headlines

Articles On GuruFocus.com
US Market Indexes Continue to Reach New Highs Dec 08 2016 
Southern Company: Dividend Achiever Nearing a 5% Yield Dec 08 2016 
Royce Funds: What's the Outlook for U.S. Small-Caps? Dec 08 2016 
Big Insider Sell at Apple, Buy at Acushnet Dec 08 2016 
Mason Hawkins Adds to FedEx Dec 08 2016 
Altria Group Announces Quarterly Dividend Dec 08 2016 
Jim Chanos Adds to Starz Dec 08 2016 
Lam Research Increases Dividend by a Solid 50% Dec 08 2016 
Avoid Advanced Micro Devices Dec 08 2016 
Lululemon Is a Buy Dec 08 2016 

More From Other Websites
How Could Gilead Sciences Restore Its Growth? Dec 01 2016
Why Neurocrine Biosciences May See Higher Losses in 2016 Dec 01 2016
5 Reasons to Buy 5 Low P/E Biotech ETFs Nov 14 2016
What Drove Regeneron’s 3Q16 Performance? Nov 09 2016
Biotech ETFs Slumping on Q3 Results Nov 08 2016
Strensiq: A Potential Driver for Alexion Nov 02 2016
Once Beloved Momentum ETF Loses Its Momo Oct 27 2016
Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech Oct 20 2016
What Are the Drivers behind the Success of Soliris? Oct 20 2016
Why Europe Is an Important Market for Vertex’s Orkambi Oct 19 2016
How Regeneron Is Working to Maintain Eylea’s Dominance Sep 29 2016
BioMarin to Cross $1 Billion Revenue in 2016 Sep 27 2016
Higher Discontinuations Are among Orkambi’s Concerns Sep 26 2016
How Ionis Pharmaceuticals’ Valuation Compares to Its Peers Sep 20 2016
Sarepta Stock Surge Boosts Some Biotech ETFs But Not Others Sep 19 2016
Inside the Recent Surge in Biotech ETFs Sep 14 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK